Skip to main content

Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

Advances in Therapy volume 33, pages 2150–2159 (2016)Cite this article

Abstract

Introduction

In numerous clinical practice guidelines, emphasis is placed on the need for coordinated care of psoriatic arthritis (PsA) between rheumatologists and the objective was to develop experience-based points to consider facilitating the implementation of multidisciplinary units (Dermatology/Rheumatology) for the management of patients with PsA.

Methods

A scientific committee of rheumatology and dermatology experts in the management of PsA, and with experience in joint care, discussed the critical aspects of multidisciplinary PsA Units. The discussion became the basis for a Delphi survey in two rounds submitted to a panel of 24 specialists in rheumatology and dermatology not involved in PsA units. The statements and practices that reached a consensus were summarized and further elaborated.

Results

After two Delphi rounds, agreement was reached for 49 of the 50 proposed statements. These included a justification of the units, objectives, and utilities, as well as operational aspects of the units, such as the minimal and ideal premises, referral criteria, and necessary resources. The statements were compiled in 11 points to consider.

Conclusions

This consensus offers some points to consider, including premises and recommendations, for the development of specialized Units in the management of PsA based on expert opinion. We trust these guidelines may facilitate their implementation in the future.

Funding

Pfizer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Dauden E, Castaneda S, Suarez C, et al. Integrated approach to comorbidity in patients with psoriasis. Working Group on Psoriasis-associated Comorbidities. Actas dermo-sifiliograficas. 2012;103(Suppl 1):1–64.

    PubMed  Google Scholar 

  2. Dhir V, Aggarwal A. Psoriatic arthritis: a critical review. Clin Rev Allergy Immunol. 2013;44(2):141–8.

    Article  PubMed  Google Scholar 

  3. Kavanaugh A. Psoriatic arthritis: treat-to-target. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S123–5.

    PubMed  Google Scholar 

  4. Cortesi PA, Scalone L, D’Angiolella L, et al. Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S126–31.

    PubMed  Google Scholar 

  5. Burgos-Pol R, Martinez-Sesmero JM, Ventura-Cerda JM, Elias I, Caloto MT, Casado MA. The cost of psoriasis and psoriatic arthritis in 5 European countries: a systematic review. Actas dermo-sifiliograficas. 2016;107(7):577–90.

    Article  CAS  PubMed  Google Scholar 

  6. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40.

    Article  PubMed  Google Scholar 

  7. Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242–8.

    Article  PubMed  Google Scholar 

  8. Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–50.

    Article  CAS  PubMed  Google Scholar 

  9. Lopez-Estebaranz JL, Zarco-Montejo P, Escalas-Taberner J, Garcia-Rodriguez M, Garcia-Llorente JF, Garcia-Calvo C. Clinical management of psoriatic arthritis in Spain: the CALIPSO study. Actas dermo-sifiliograficas. 2010;101(7):629–36.

    Article  CAS  PubMed  Google Scholar 

  10. Migliore A, Cusano F, Bianchi G, Malara G, Epis O, De Pita O. Management of psoriatic arthritis: should the interaction between dermatologists and rheumatologists in clinical practice be intensified? J Biol Regul Homeost Agents. 2015;29(3):547–61.

    CAS  PubMed  Google Scholar 

  11. Gossec L, Smolen JS, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012;71(1):4–12.

    Article  CAS  PubMed  Google Scholar 

  12. Coates LC, Tillett W, Chandler D, et al. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology. 2013;52(10):1754–7.

    Article  PubMed  Google Scholar 

  13. National Institute for Health and Care Excellence (NICE). Psoriasis: The assessment and management of psoriasis. NICE guidelines [CG153]. 2012. https://www.nice.org.uk/guidance/cg153.

  14. Canete JD, Dauden E, Queiro R, et al. Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study. Actas dermo-sifiliograficas. 2014;105(3):216–32.

    Article  CAS  PubMed  Google Scholar 

  15. Pérez-Barrio S, Galíndez E, Alzaga JMC, García-Vivar ML, Urigoitia P, Belloso RI. Psoriasis and psoriatic arthropathy multidisciplinary clinic at Basurto University Hospital: 2 years of experience. J Am Acad Dermatol. 2014;70(5):AB180.

    Google Scholar 

  16. Luelmo J, Gratacos J, Martinez-Losa MM, et al. A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis. Reumatol Clin. 2014;10(3):141–6.

    Article  PubMed  Google Scholar 

  17. Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res. 2012;304(1):7–13.

    Article  PubMed  Google Scholar 

  18. Sasaki JL, Koo JY. Skin therapies: dermatologic perspective on the rheumatology–dermatology interface. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S78–81.

    PubMed  Google Scholar 

  19. Hatton J, Burton A, Nash H, Munn E, Burgoyne L, Sheron N. Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction. 2009;104(4):587–92.

    Article  PubMed  Google Scholar 

  20. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Centre for Evidence-Based Medicine (CEBM). Oxford Centre for Evidence-based Medicine-Levels of Evidence. 2009. http://www.cebm.net/oxford-centre-evidencebased-medicine-levels-evidence-march-2009/.

  22. Fernandez Sueiro JL, Juanola Roura X, Canete Crespillo Jde D, et al. Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis. Reumatol Clin. 2011;7(3):179–88.

    Article  PubMed  Google Scholar 

  23. Lopez-Ferrer A, Torrente-Segarra V, Puig L. Psoriatic arthritis: what the dermatologist needs to know, Part 2. Actas dermo-sifiliograficas. 2010;101(9):742–8.

    Article  CAS  PubMed  Google Scholar 

  24. Lopez-Ferrer A, Torrente-Segarra V, Puig L. Psoriatic arthritis: what the dermatologist needs to know, part 1. Actas dermo-sifiliograficas. 2010;101(7):578–84.

    Article  CAS  PubMed  Google Scholar 

  25. Cobo-Ibanez T, Villaverde V, Seoane-Mato D, et al. Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review. Rheumatol Int. 2016;36(2):221–9.

    Article  PubMed  Google Scholar 

  26. Sociedad Española de Reumatología. ESPOGUÍA: guía de práctica clínica sobre el manejo de los pacientes con Espondiloartritis. Madrid: Sociedad Española de Reumatología; 2009 [updated 20 septiembre 2013]. http://www.ser.es/practicaClinica/espoguia/index.php.

  27. Coates LC, Navarro-Coy N, Brown SR, et al. The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord. 2013;14:101.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Burden AD, Hilton Boon M, Leman J, et al. Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance. BMJ. 2010;341:c5623.

    Article  CAS  PubMed  Google Scholar 

  29. Coates LC, Moverley AR, McParland L, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489–98.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Queiro R, Coto P, Rodríguez J, et al. Multidisciplinary care models for patients with psoriatic arthritis. Reumatol Clin. 2016. doi:10.1016/j.reuma.2016.03.005 ([Epub ahead of print] English, Spanish).

  31. Betteridge N, Boehncke WH, Bundy C, et al. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol. 2016;30(4):576–85. doi:10.1111/jdv.13306 [Epub 2015 Sep 16].

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to make a special mention and show their gratitude to the panelists that participated to the voting according to the Delphi methodology and prepared this document: Mariano Ara Martin, Jose Luis Alvarez Vega, Sagrario Bustabad Reyes, Antonio Javier Chaves Alvarez, Pablo de la Cueva Dobao, Concepción Delgado Beltran, Carmen Maria Escudero Gonzalez, Eva Galindez Agirregoikoa, Francisco Jose Guimera Martin-Neda, Rosa Izu Belloso, Gemma Marquez Balbas, Amparo Marquina Vila, Angels Martinez Ferrer, Lourdes Mateo Soria, Virginia Moreira Navarrete, Maria Teresa Navio Marco, Susana Perez Santos, Alberto Romero Mate, Inmaculada Ros Vilamajo, Rosa Taberner Ferrer, Claudia Urrego Laurin, Ana Urruticoechea Arana, Raul Veiga Cabello, and Beatriz Yoldi Muñoz. The authors also appreciate the editorial support given by Nature Publishing Group Iberoamerica and Dr Pablo Rivas in the preparation of this manuscript. The scientific meetings, Delphi survey, and medical writing services were funded by Pfizer Spain. No funding was received for publication charges. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.

Disclosures

Jordi Gratacos has received a speaker honorarium from Company MSD, Pfizer, Novartis, Janssen, Celgene and Abbvie. Pedro Zarco has received a speaker honorarium from Company MSD, Pfizer, Novartis, Janssen, Celgene and Abbvie. Ana M. Carrizosa-Esquivel has received a speaker honorarium from Company MSD, Pfizer, Novartis, Janssen, Celgene and Abbvie. M. Dolores Ruiz-Montesino has received a speaker honorarium from Company MSD, Pfizer, Novartis, Janssen, Celgene and Abbvie. Jose Antonio Román-Ivorra has received a speaker honorarium from Company MSD, Pfizer, Novartis, Janssen, Celgene and Abbvie. Jesus Luelmo has received a speaker honorarium from Company Pfizer, Novartis, Janssen, Celgene and Abbvie. Rafael Botella-Estrada has received a speaker honorarium from Company Pfizer, Novartis, Janssen, Celgene and Abbvie. M. Luz Garcia-Vivar has received a speaker honorarium from Company Pfizer, Novartis, Janssen, Celgene and Abbvie. Silvia Perez-Barrio has received a speaker honorarium from Company Pfizer, Novartis, Janssen, Celgene and Abbvie. Jose Luis Lopez-Estebaranz has received a speaker honorarium from Company Pfizer, Novartis, Janssen, Celgene and Abbvie. None of these companies had any role in the date of the study or in the elaboration of the final manuscript.

Compliance with Ethics Guidelines

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2013. Informed consent was obtained from all patients for being included in the study.

Author information

Authors and Affiliations

  1. Hospital Universitario Parc Tauli de Sabadell, IPT.UAB, Barcelona, Spain

    Jordi Gratacos-Masmitja & Jesus Luelmo-Aguilar

  2. Alcorcon Foundation University Hospital, Madrid, Spain

    Pedro Zarco-Montejo & Jose Luis Lopez-Estebaranz

  3. Hospital Universitari i Politecnic La Fe, Barcelona, Spain

    Rafael Botella-Estrada

  4. Virgen Macarena Hospital, Seville, Spain

    Ana Maria Carrizosa-Esquivel & Maria Dolores Ruiz-Montesino

  5. Basurto University Hospital, Bilbao, Spain

    Maria Luz Garcia-Vivar & Silvia Perez-Barrio

  6. Hospital Universitari i Politecnic La Fe, Valencia, Spain

    Jose Antonio Roman-Ivorra

Authors
  1. Jordi Gratacos-Masmitja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jesus Luelmo-Aguilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pedro Zarco-Montejo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rafael Botella-Estrada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Maria Carrizosa-Esquivel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Luz Garcia-Vivar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Silvia Perez-Barrio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jose Antonio Roman-Ivorra
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maria Dolores Ruiz-Montesino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jose Luis Lopez-Estebaranz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jordi Gratacos-Masmitja.

Additional information

Enhanced content

To view enhanced content for this article go to http://www.medengine.com/Redeem/E1E6F06018DB528D.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gratacos-Masmitja, J., Luelmo-Aguilar, J., Zarco-Montejo, P. et al. Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature. Adv Ther 33, 2150–2159 (2016). https://doi.org/10.1007/s12325-016-0429-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-016-0429-z

Keywords

  • Biological therapy
  • Consensus development
  • Dermatology
  • Organizations
  • Hospital units
  • Multidisciplinary care
  • Psoriasis
  • Psoriatic arthritis
  • Rheumatology